Enfermedades retinianas y nuevas terapias
Publicaciones (60) Publicaciones en las que ha participado algún/a investigador/a
2024
-
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021–2030): a societal perspective
Health Economics Review, Vol. 14, Núm. 1
-
Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Ophthalmic Research, pp. 516-527
-
Conjunctival ultraviolet autofluorescence as a biomarker of outdoor exposure in myopia: a systematic review and meta-analysis
Scientific Reports, Vol. 14, Núm. 1
-
Could Children’s Myopization Have Been Avoided during the Pandemic Confinement? The Conjunctival Ultraviolet Autofluorescence (CUVAF) Biomarker as an Answer
Biomedicines, Vol. 12, Núm. 2
-
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials
Ophthalmology, Vol. 131, Núm. 6, pp. 708-723
-
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration
Ophthalmology Retina, Vol. 8, Núm. 4, pp. 350-359
-
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
Ophthalmic research, Vol. 67, Núm. 1, pp. 311-321
-
Suitability of machine learning for atrophy and fibrosis development in neovascular age-related macular degeneration
Acta Ophthalmologica, Vol. 102, Núm. 5, pp. e831-e841
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
Ophthalmology, Vol. 131, Núm. 8, pp. 914-926
-
The Scavenging Activity of Coenzyme Q10 Plus a Nutritional Complex on Human Retinal Pigment Epithelial Cells
International Journal of Molecular Sciences, Vol. 25, Núm. 15
-
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmology and Therapy, Vol. 13, Núm. 9, pp. 2343-2355
2023
-
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration
Ophthalmology, Vol. 130, Núm. 6, pp. 588-597
-
Análisis coste-utilidad del modelo de unidad de terapia intravítrea (UTI) frente a la administración tradicional de terapia intravítrea
Archivos de la Sociedad Española de Oftalmologia, Vol. 98, Núm. 11, pp. 619-626
-
Blue Light Exposure: Ocular Hazards and Prevention—A Narrative Review
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 755-788
-
Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study
International Ophthalmology, Vol. 43, Núm. 12, pp. 4639-4649
-
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
The Lancet, Vol. 402, Núm. 10411, pp. 1449-1458
-
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
Japanese Journal of Ophthalmology, Vol. 67, Núm. 3, pp. 264-279
-
Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization
Antioxidants, Vol. 12, Núm. 4
-
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood
Biological Psychiatry, Vol. 93, Núm. 9, pp. 770-779
2022
-
A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)
Journal of Clinical Medicine, Vol. 11, Núm. 15